US Stock MarketDetailed Quotes

WENA Anew Medical

Watchlist

2.035
+0.235+13.06%

Trading Jul 2 09:53 ET

22.31MMarket Cap-8140P/E (TTM)

Anew Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.98K

-111.10%-599.57K

-284.02K

Net income from continuing operations

---672.04K

46.03%-598.59K

---1.11M

Change In working capital

--362.82K

-161.75%-2.38K

--3.85K

-Change in prepaid assets

--3.84K

--0

--1.62K

-Change in payables and accrued expense

--358.98K

-206.30%-2.38K

--2.24K

Cash from discontinued investing activities

Operating cash flow

---21.98K

-111.10%-599.57K

---284.02K

Investing cash flow

Cash flow from continuing investing activities

-123.5K

-125.41K

0

Net intangibles purchase and sale

---123.5K

---125.41K

--0

Cash from discontinued investing activities

Investing cash flow

---123.5K

---125.41K

--0

Financing cash flow

Cash flow from continuing financing activities

175K

100.00%500K

250K

Net common stock issuance

--50K

200.00%750K

--250K

Net preferred stock issuance

--125K

----

----

Net other financing activities

----

---250K

----

Cash from discontinued financing activities

Financing cash flow

--175K

100.00%500K

--250K

Net cash flow

Beginning cash position

--2.81K

-10.16%300.85K

--334.87K

Current changes in cash

--29.53K

-561.30%-224.98K

---34.02K

End cash Position

--32.34K

-74.78%75.87K

--300.85K

Free cash flow

---145.47K

-155.26%-724.98K

---284.02K

Currency Unit

USD

USD

USD

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.98K	-111.10%-599.57K	-284.02K
Net income from continuing operations	---672.04K	46.03%-598.59K	---1.11M
Change In working capital	--362.82K	-161.75%-2.38K	--3.85K
-Change in prepaid assets	--3.84K	--0	--1.62K
-Change in payables and accrued expense	--358.98K	-206.30%-2.38K	--2.24K
Cash from discontinued investing activities
Operating cash flow	---21.98K	-111.10%-599.57K	---284.02K
Investing cash flow
Cash flow from continuing investing activities	-123.5K	-125.41K	0
Net intangibles purchase and sale	---123.5K	---125.41K	--0
Cash from discontinued investing activities
Investing cash flow	---123.5K	---125.41K	--0
Financing cash flow
Cash flow from continuing financing activities	175K	100.00%500K	250K
Net common stock issuance	--50K	200.00%750K	--250K
Net preferred stock issuance	--125K	----	----
Net other financing activities	----	---250K	----
Cash from discontinued financing activities
Financing cash flow	--175K	100.00%500K	--250K
Net cash flow
Beginning cash position	--2.81K	-10.16%300.85K	--334.87K
Current changes in cash	--29.53K	-561.30%-224.98K	---34.02K
End cash Position	--32.34K	-74.78%75.87K	--300.85K
Free cash flow	---145.47K	-155.26%-724.98K	---284.02K
Currency Unit	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall